{"transactions":[{"id":921249,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":1,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":2,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-03T21:05:18.000Z","date":"2025-12-10","kind":"sale","planned":false,"acquired":false,"shares":555555,"price":23.37,"value":12983320.35,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities reported herein were held by HACF, L.P., an exempted Cayman Islands limited partnership (\"HACF\"). HHLR (as defined below) acts as the sole management company of HACF."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The securities reported herein are held by VSUM VI Holdings Limited (\"VSUM VI\"), VSUM VIII Holdings Limited (\"VSUM VIII\") and ARVT Holdings Limited (\"ARVT\"). VSUM VI is a wholly owned subsidiary of Hillhouse Venture Fund V, L.P. (\"Venture Fund V\"), VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare Fund, L.P. (\"Healthcare Fund\") and ARVT is a wholly owned subsidiary of Hillhouse Venture Fund VI, L.P. (\"Venture Fund VI\"). HIM (as defined below) acts as the sole management company of each of Venture Fund V, Healthcare Fund and Venture Fund VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This statement is filed by (i) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\") and (ii) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HIM and HHLR are under common control and share certain policies, personnel and resources. Accordingly, HIM and HHLR are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The filing of this statement shall not be deemed an admission that each of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any."}],"balance_after":3929117,"source":{"system":"sec-edgar","filing":"0000902664-26-000675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266426000675/ownership.xml","form_type":"4"}},{"id":1342593,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":1,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":2,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2024-12-04T21:06:08.000Z","date":"2024-12-02","kind":"sale","planned":false,"acquired":false,"shares":17842500,"price":200,"value":3568500000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The ordinary shares, par value $0.0001 per share (\"Ordinary Shares\") sold were in the form of American Depositary Shares (\"ADSs\"). The reported price is the price of each ADS sold; the price was paid in USD. Each ADS represents 13 Ordinary Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 111,597,423 Ordinary Shares held by funds managed by HHLR (as defined below), of which 36,011,300 Ordinary Shares are held in the form of 2,770,100 ADSs and (ii) 13,448,318 Ordinary Shares held by a fund managed by HIM (as defined below), of which 13,445,978 Ordinary Shares are held in the form of 1,034,306 ADSs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This form is filed by (i) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\"), and (ii) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HHLR and HIM are under common control and share certain policies, personnel and resources. Accordingly, HHLR and HIM are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities to which this filing relates are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership (\"HHLR Fund\"), and BGN Holdings Limited, an exempted Cayman Islands company (\"BGN\"). HHLR acts as the sole management company of HHLR Fund. HIM acts as the sole management company of Hillhouse Fund II, L.P. (\"Fund II\"). BGN is wholly owned by Fund II. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any."}],"balance_after":125045741,"source":{"system":"sec-edgar","filing":"0000902664-24-006828","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266424006828/ownership.xml","form_type":"4"}},{"id":1663723,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":1,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":2,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-02-01T21:47:58.000Z","date":"2024-01-30","kind":"exercise","planned":false,"acquired":false,"shares":4761903,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series B Preferred Stock converted into shares of common stock on a 15.21-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"The securities reported herein are held by VSUM VIII and ARVT Holdings Limited (\"ARVT\"). VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare and ARVT is a wholly owned subsidiary of Hillhouse Venture Fund VI, L.P. (\"Hillhouse Venture VI\"). HIM acts as the sole management company of each of Hillhouse Healthcare and Hillhouse Venture VI."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series B Preferred Stock converted into shares of common stock on a 15.21-for-1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series B Preferred Stock converted into shares of common stock on a 15.21-for-1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This statement is filed by (i) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\") and (ii) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HIM and HHLR are under common control and share certain policies, personnel and resources. Accordingly, HIM and HHLR are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The filing of this statement shall not be deemed an admission that each of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":313076},"source":{"system":"sec-edgar","filing":"0000902664-24-000903","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266424000903/ownership.xml","form_type":"4"}},{"id":1663722,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":1,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":2,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2024-02-01T21:47:58.000Z","date":"2024-01-30","kind":"exercise","planned":false,"acquired":false,"shares":55000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series B Preferred Stock converted into shares of common stock on a 15.21-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The securities reported herein are held by VSUM VI Holdings Limited (\"VSUM VI\") and VSUM VIII Holdings Limited (\"VSUM VIII\"). VSUM VI is a wholly owned subsidiary of Hillhouse Venture Fund V, L.P. (\"Hillhouse Venture V\") and VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare Fund, L.P. (\"Hillhouse Healthcare\"). HIM (as defined below) acts as the sole management company of each of Hillhouse Venture V and Hillhouse Healthcare."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series B Preferred Stock converted into shares of common stock on a 15.21-for-1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series B Preferred Stock converted into shares of common stock on a 15.21-for-1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This statement is filed by (i) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\") and (ii) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HIM and HHLR are under common control and share certain policies, personnel and resources. Accordingly, HIM and HHLR are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The filing of this statement shall not be deemed an admission that each of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3616041},"source":{"system":"sec-edgar","filing":"0000902664-24-000903","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266424000903/ownership.xml","form_type":"4"}},{"id":1663721,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":1,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":2,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-01T21:47:58.000Z","date":"2024-01-30","kind":"purchase","planned":false,"acquired":true,"shares":555555,"price":18,"value":9999990.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The securities reported herein are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership (\"HHLR Fund\"). HHLR (as defined below) acts as the sole management company of HHLR Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This statement is filed by (i) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\") and (ii) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HIM and HHLR are under common control and share certain policies, personnel and resources. Accordingly, HIM and HHLR are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The filing of this statement shall not be deemed an admission that each of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any."}],"balance_after":4484672,"source":{"system":"sec-edgar","filing":"0000902664-24-000903","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266424000903/ownership.xml","form_type":"4"}},{"id":1663720,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":1,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":2,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-01T21:47:58.000Z","date":"2024-01-30","kind":"exercise","planned":false,"acquired":true,"shares":313076,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The securities reported herein are held by VSUM VI Holdings Limited (\"VSUM VI\") and VSUM VIII Holdings Limited (\"VSUM VIII\"). VSUM VI is a wholly owned subsidiary of Hillhouse Venture Fund V, L.P. (\"Hillhouse Venture V\") and VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare Fund, L.P. (\"Hillhouse Healthcare\"). HIM (as defined below) acts as the sole management company of each of Hillhouse Venture V and Hillhouse Healthcare."},{"field":"shares","element":"transactionShares","label":"F3","text":"The securities reported herein are held by VSUM VIII and ARVT Holdings Limited (\"ARVT\"). VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare and ARVT is a wholly owned subsidiary of Hillhouse Venture Fund VI, L.P. (\"Hillhouse Venture VI\"). HIM acts as the sole management company of each of Hillhouse Healthcare and Hillhouse Venture VI."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series B Preferred Stock converted into shares of common stock on a 15.21-for-1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This statement is filed by (i) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\") and (ii) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HIM and HHLR are under common control and share certain policies, personnel and resources. Accordingly, HIM and HHLR are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The filing of this statement shall not be deemed an admission that each of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any."}],"balance_after":3929117,"source":{"system":"sec-edgar","filing":"0000902664-24-000903","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266424000903/ownership.xml","form_type":"4"}},{"id":1663719,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":1,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":2,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-01T21:47:58.000Z","date":"2024-01-30","kind":"exercise","planned":false,"acquired":true,"shares":3616041,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The securities reported herein are held by VSUM VI Holdings Limited (\"VSUM VI\") and VSUM VIII Holdings Limited (\"VSUM VIII\"). VSUM VI is a wholly owned subsidiary of Hillhouse Venture Fund V, L.P. (\"Hillhouse Venture V\") and VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare Fund, L.P. (\"Hillhouse Healthcare\"). HIM (as defined below) acts as the sole management company of each of Hillhouse Venture V and Hillhouse Healthcare."},{"field":"shares","element":"transactionShares","label":"F3","text":"The securities reported herein are held by VSUM VIII and ARVT Holdings Limited (\"ARVT\"). VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare and ARVT is a wholly owned subsidiary of Hillhouse Venture Fund VI, L.P. (\"Hillhouse Venture VI\"). HIM acts as the sole management company of each of Hillhouse Healthcare and Hillhouse Venture VI."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series B Preferred Stock converted into shares of common stock on a 15.21-for-1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This statement is filed by (i) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\") and (ii) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HIM and HHLR are under common control and share certain policies, personnel and resources. Accordingly, HIM and HHLR are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The filing of this statement shall not be deemed an admission that each of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any."}],"balance_after":3616041,"source":{"system":"sec-edgar","filing":"0000902664-24-000903","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266424000903/ownership.xml","form_type":"4"}},{"id":1853967,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":1,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":2,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-15T23:25:01.000Z","date":"2023-06-14","kind":"sale","planned":false,"acquired":false,"shares":273728,"price":207.7171,"value":56857986.3488,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares sold were in the form of ADS. The reported price is the price of each ADS sold, the price was paid in USD. Each ADS represents 13 Ordinary Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 129,439,923 ordinary shares held by funds managed by HHLR (as defined below), of which 53,853,800 ordinary shares are held in the form of 4,142,600 ADSs and (ii) 13,448,318 ordinary shares held by a fund managed by HIM (as defined below), of which 13,445,978 ordinary shares are held in the form of 1,034,306 ADSs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This form is filed by (i) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\") and (ii) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HHLR and HIM are under common control and share certain policies, personnel and resources. Accordingly, HHLR and HIM are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The securities to which this filing relates are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership (\"HHLR Fund\"), YHG Investment, L.P., an exempted Cayman Islands limited partnership (\"YHG\"), and BGN Holdings Limited, an exempted Cayman Islands company (\"BGN\"). HHLR acts as the sole management company of HHLR Fund and the sole investment manager of YHG. HIM acts as the sole management company of Hillhouse Fund II, L.P. (\"Fund II\"). BGN is wholly owned by Fund II. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":142888241,"source":{"system":"sec-edgar","filing":"0000902664-23-003603","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266423003603/ownership.xml","form_type":"4"}},{"id":1853966,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":1,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":2,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-15T23:25:01.000Z","date":"2023-06-13","kind":"sale","planned":false,"acquired":false,"shares":313400,"price":128.4335,"value":40251058.9,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The ordinary shares were sold through the Stock Exchange of Hong Kong, the price was paid in HKD."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from HKD127.75 to HKD128.5985, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ordinary shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This form is filed by (i) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\") and (ii) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HHLR and HIM are under common control and share certain policies, personnel and resources. Accordingly, HHLR and HIM are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The securities to which this filing relates are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership (\"HHLR Fund\"), YHG Investment, L.P., an exempted Cayman Islands limited partnership (\"YHG\"), and BGN Holdings Limited, an exempted Cayman Islands company (\"BGN\"). HHLR acts as the sole management company of HHLR Fund and the sole investment manager of YHG. HIM acts as the sole management company of Hillhouse Fund II, L.P. (\"Fund II\"). BGN is wholly owned by Fund II. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":143161969,"source":{"system":"sec-edgar","filing":"0000902664-23-003603","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266423003603/ownership.xml","form_type":"4"}},{"id":1853965,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":1,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":2,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-15T23:25:01.000Z","date":"2023-06-13","kind":"sale","planned":false,"acquired":false,"shares":611000,"price":211.4522,"value":129197294.2,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares sold were in the form of ADS. The reported price is the price of each ADS sold, the price was paid in USD. Each ADS represents 13 Ordinary Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This form is filed by (i) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\") and (ii) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HHLR and HIM are under common control and share certain policies, personnel and resources. Accordingly, HHLR and HIM are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The securities to which this filing relates are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership (\"HHLR Fund\"), YHG Investment, L.P., an exempted Cayman Islands limited partnership (\"YHG\"), and BGN Holdings Limited, an exempted Cayman Islands company (\"BGN\"). HHLR acts as the sole management company of HHLR Fund and the sole investment manager of YHG. HIM acts as the sole management company of Hillhouse Fund II, L.P. (\"Fund II\"). BGN is wholly owned by Fund II. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":143475369,"source":{"system":"sec-edgar","filing":"0000902664-23-003603","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266423003603/ownership.xml","form_type":"4"}},{"id":1858432,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":1,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":2,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-13T01:57:48.000Z","date":"2023-06-12","kind":"sale","planned":false,"acquired":false,"shares":968812,"price":213.9125,"value":207240996.95,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares sold were in the form of ADS. The reported price is the price of each ADS sold, the price was paid in USD. Each ADS represents 13 Ordinary Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of (i) 130,638,051 ordinary shares held by funds managed by HHLR (as defined below), of which 54,737,800 ordinary shares are held in the form of 4,210,600 ADSs and (ii) 13,448,318 ordinary shares held by a fund managed by HIM (as defined below), of which 13,445,978 ordinary shares are held in the form of 1,034,306 ADSs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This form is filed by (i) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\") and (ii) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HHLR and HIM are under common control and share certain policies, personnel and resources. Accordingly, HHLR and HIM are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities to which this filing relates are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership (\"HHLR Fund\"), YHG Investment, L.P., an exempted Cayman Islands limited partnership (\"YHG\"), and BGN Holdings Limited, an exempted Cayman Islands company (\"BGN\"). HHLR acts as the sole management company of HHLR Fund and the sole investment manager of YHG. HIM acts as the sole management company of Hillhouse Fund II, L.P. (\"Fund II\"). BGN is wholly owned by Fund II. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":144086369,"source":{"system":"sec-edgar","filing":"0000902664-23-003537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266423003537/ownership.xml","form_type":"4"}},{"id":1858431,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":1,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":2,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-13T01:57:48.000Z","date":"2023-06-12","kind":"sale","planned":false,"acquired":false,"shares":281400,"price":130.8322,"value":36816181.08,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The ordinary shares were sold through the Stock Exchange of Hong Kong, the price was paid in HKD."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from HKD131.7943 to HKD131.0298 inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ordinary shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This form is filed by (i) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\") and (ii) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HHLR and HIM are under common control and share certain policies, personnel and resources. Accordingly, HHLR and HIM are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities to which this filing relates are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership (\"HHLR Fund\"), YHG Investment, L.P., an exempted Cayman Islands limited partnership (\"YHG\"), and BGN Holdings Limited, an exempted Cayman Islands company (\"BGN\"). HHLR acts as the sole management company of HHLR Fund and the sole investment manager of YHG. HIM acts as the sole management company of Hillhouse Fund II, L.P. (\"Fund II\"). BGN is wholly owned by Fund II. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":145055181,"source":{"system":"sec-edgar","filing":"0000902664-23-003537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266423003537/ownership.xml","form_type":"4"}},{"id":1858430,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":1,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":2,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-13T01:57:48.000Z","date":"2023-06-09","kind":"sale","planned":false,"acquired":false,"shares":328952,"price":217.0183,"value":71388603.8216,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares sold were in the form of ADS. The reported price is the price of each ADS sold, the price was paid in USD. Each ADS represents 13 Ordinary Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This form is filed by (i) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\") and (ii) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HHLR and HIM are under common control and share certain policies, personnel and resources. Accordingly, HHLR and HIM are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities to which this filing relates are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership (\"HHLR Fund\"), YHG Investment, L.P., an exempted Cayman Islands limited partnership (\"YHG\"), and BGN Holdings Limited, an exempted Cayman Islands company (\"BGN\"). HHLR acts as the sole management company of HHLR Fund and the sole investment manager of YHG. HIM acts as the sole management company of Hillhouse Fund II, L.P. (\"Fund II\"). BGN is wholly owned by Fund II. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":145336581,"source":{"system":"sec-edgar","filing":"0000902664-23-003537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266423003537/ownership.xml","form_type":"4"}},{"id":1858429,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":1,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":2,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-13T01:57:48.000Z","date":"2023-06-09","kind":"sale","planned":false,"acquired":false,"shares":213700,"price":130.3523,"value":27856286.51,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The ordinary shares were sold through the Stock Exchange of Hong Kong, the price was paid in HKD."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from HKD130.2787 to HKD130.550, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ordinary shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This form is filed by (i) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\") and (ii) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HHLR and HIM are under common control and share certain policies, personnel and resources. Accordingly, HHLR and HIM are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities to which this filing relates are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership (\"HHLR Fund\"), YHG Investment, L.P., an exempted Cayman Islands limited partnership (\"YHG\"), and BGN Holdings Limited, an exempted Cayman Islands company (\"BGN\"). HHLR acts as the sole management company of HHLR Fund and the sole investment manager of YHG. HIM acts as the sole management company of Hillhouse Fund II, L.P. (\"Fund II\"). BGN is wholly owned by Fund II. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":145665533,"source":{"system":"sec-edgar","filing":"0000902664-23-003537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266423003537/ownership.xml","form_type":"4"}},{"id":1858428,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":1,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":2,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-13T01:57:48.000Z","date":"2023-06-08","kind":"sale","planned":false,"acquired":false,"shares":1163825,"price":218.1443,"value":253881789.9475,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares sold were in the form of ADS. The reported price is the price of each ADS sold, the price was paid in USD. Each ADS represents 13 Ordinary Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This form is filed by (i) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\") and (ii) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HHLR and HIM are under common control and share certain policies, personnel and resources. Accordingly, HHLR and HIM are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities to which this filing relates are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership (\"HHLR Fund\"), YHG Investment, L.P., an exempted Cayman Islands limited partnership (\"YHG\"), and BGN Holdings Limited, an exempted Cayman Islands company (\"BGN\"). HHLR acts as the sole management company of HHLR Fund and the sole investment manager of YHG. HIM acts as the sole management company of Hillhouse Fund II, L.P. (\"Fund II\"). BGN is wholly owned by Fund II. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":145879233,"source":{"system":"sec-edgar","filing":"0000902664-23-003537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266423003537/ownership.xml","form_type":"4"}},{"id":2174787,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":67918,"kind":"organization","name":"HHLR ADVISORS, LTD.","position":1,"cik":"0001762304","reported_name":"HHLR ADVISORS, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":2,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-24T20:15:49.000Z","date":"2022-08-22","kind":"other","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer of shares by Qingqing Yi (\"Mr. Yi\"), a director of the Issuer and an employee of the Reporting Persons (as defined below), to certain funds managed by the Reporting Persons and for whose benefit he was holding the shares. The Reporting Persons expressly disclaim beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 133,594,740 ordinary shares held by funds managed by HHLR (as defined below), of which 127,971,155 ordinary shares are held in the form of 9,843,935 ADSs and (ii) 13,448,318 ordinary shares held by a fund managed by HIM (as defined below), of which 13,447,603 ordinary shares are held in the form of 1,034,431 ADSs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This form is filed by (i) HHLR Advisors, Ltd., an exempted Cayman Islands company (\"HHLR\") and (ii) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (\"HIM\"). The foregoing persons are hereinafter sometimes each referred to as a \"Reporting Person\" and collectively referred to as the \"Reporting Persons.\" HHLR and HIM are under common control and share certain policies, personnel and resources. Accordingly, HHLR and HIM are filing this Form 4 jointly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities to which this filing relates are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership (\"HHLR Fund\"), YHG Investment, L.P., an exempted Cayman Islands limited partnership (\"YHG\"), and BGN Holdings Limited, an exempted Cayman Islands company (\"BGN\"). HHLR acts as the sole management company of HHLR Fund and the sole investment manager of YHG. HIM acts as the sole management company of Hillhouse Fund II, L.P. (\"Fund II\"). BGN is wholly owned by Fund II. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":147043058,"source":{"system":"sec-edgar","filing":"0000902664-22-004100","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510589/000090266422004100/ownership.xml","form_type":"4"}},{"id":2534102,"issuer":{"id":80590,"kind":"organization","name":"Enfusion, Inc.","symbol":"ENFN"},"owners":[{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":1,"cik":"0001510589","reported_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A common stock, par value $0.001 per share","published_at":"2021-10-27T16:20:37.000Z","date":"2021-10-25","kind":"sale","acquired":false,"shares":647862,"price":15.895,"value":10297766.49,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock sold to the underwriters in the issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities to which this filing relates are held directly by ELL Investments, L.P. (\"ELL\"), a wholly owned subsidiary of Hillhouse Fund IV, L.P. (\"Fund IV\"). Hillhouse Investment Management, Ltd. (the \"Reporting Person\") acts as the sole management company of Fund IV and as such may be deemed to be the beneficial owner of, and to control the voting power of, the shares of Class A common stock held by ELL. The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":4975183,"source":{"system":"sec-edgar","filing":"0000902664-21-004622","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868912/000090266421004622/ownership.xml","form_type":"4"}},{"id":4162168,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":1,"cik":"0001510589","reported_name":"Hillhouse Capital Management, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2017-11-15T21:32:06.000Z","date":"2017-11-13","kind":"exercise","acquired":true,"shares":4476275,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D Convertible Preferred Stock was convertible at any time, at the holder's election, into shares of the Issuer's common stock, $0.0001 par value (\"Common Stock\") on a 2.133-for-1 basis. The Series D Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 2.133-for-1 basis upon the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock did not have an expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D Convertible Preferred Stock was convertible at any time, at the holder's election, into shares of the Issuer's common stock, $0.0001 par value (\"Common Stock\") on a 2.133-for-1 basis. The Series D Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 2.133-for-1 basis upon the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock did not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D Convertible Preferred Stock was convertible at any time, at the holder's election, into shares of the Issuer's common stock, $0.0001 par value (\"Common Stock\") on a 2.133-for-1 basis. The Series D Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 2.133-for-1 basis upon the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock did not have an expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported on this line are held directly by Hillhouse WHP Holdings Limited, a company incorporated under the laws of the British Virgin Islands (\"WHP\"). WHP is owned by Hillhouse Fund II, L.P., a Cayman Islands limited partnership (\"Fund II\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Hillhouse Capital Management, Ltd., an exempted Cayman Islands company (\"Hillhouse Capital\" or the \"Reporting Person\") acts as the sole management company of Fund II and Gaoling and the sole general partner of YHG. Hillhouse Capital is deemed to be the sole beneficial owner of, and to control the investment and voting power of, the securities held by the Hillhouse Entities. The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or other\nwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2098581},"source":{"system":"sec-edgar","filing":"0000902664-17-004362","document":"p17-2141form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000090266417004362/p17-2141form4.xml","form_type":"4"}},{"id":4162167,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":1,"cik":"0001510589","reported_name":"Hillhouse Capital Management, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-15T21:32:06.000Z","date":"2017-11-13","kind":"purchase","acquired":true,"shares":1428571,"price":14,"value":19999994.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported on this line are held directly by (i) Gaoling Fund, L.P., an exempted Cayman Islands limited partnership (\"Gaoling\") and (ii) YHG Investment, L.P., an exempted Cayman limited partnership (\"YHG\" and together with WHP and Gaoling, the \"Hillhouse Entities\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Hillhouse Capital Management, Ltd., an exempted Cayman Islands company (\"Hillhouse Capital\" or the \"Reporting Person\") acts as the sole management company of Fund II and Gaoling and the sole general partner of YHG. Hillhouse Capital is deemed to be the sole beneficial owner of, and to control the investment and voting power of, the securities held by the Hillhouse Entities. The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or other\nwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":3527152,"source":{"system":"sec-edgar","filing":"0000902664-17-004362","document":"p17-2141form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000090266417004362/p17-2141form4.xml","form_type":"4"}},{"id":4162166,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":67917,"kind":"organization","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","position":1,"cik":"0001510589","reported_name":"Hillhouse Capital Management, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-15T21:32:06.000Z","date":"2017-11-13","kind":"exercise","acquired":true,"shares":2098581,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series D Convertible Preferred Stock was convertible at any time, at the holder's election, into shares of the Issuer's common stock, $0.0001 par value (\"Common Stock\") on a 2.133-for-1 basis. The Series D Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 2.133-for-1 basis upon the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock did not have an expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported on this line are held directly by Hillhouse WHP Holdings Limited, a company incorporated under the laws of the British Virgin Islands (\"WHP\"). WHP is owned by Hillhouse Fund II, L.P., a Cayman Islands limited partnership (\"Fund II\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Hillhouse Capital Management, Ltd., an exempted Cayman Islands company (\"Hillhouse Capital\" or the \"Reporting Person\") acts as the sole management company of Fund II and Gaoling and the sole general partner of YHG. Hillhouse Capital is deemed to be the sole beneficial owner of, and to control the investment and voting power of, the securities held by the Hillhouse Entities. The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or other\nwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein."}],"balance_after":2098581,"source":{"system":"sec-edgar","filing":"0000902664-17-004362","document":"p17-2141form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000090266417004362/p17-2141form4.xml","form_type":"4"}}]}